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ABSTRACT 
 
CHARACTERIZING THE ROLE OF DNA POLYMERASE GAMMA IN THE YEAST, 
CRYPTOCOCCUS NEOFORMANS 
Joshua Ellis Boggs, Master of Science in Biology 
Western Carolina University (November 7, 2017) 
Director: Indrani Bose 
 
The basidiomycetous yeast, Cryptococcus neoformans, is an opportunistic pathogen that is 
responsible for a common fungal infection of the central nervous system, cryptococcal 
meningoencephalitis. This is a signal disease of AIDs patients that can also be found in patients 
of other immune compromising afflictions. This disease can be treated with various antifungal 
medications, but these drugs must be taken in combination, and are often far too expensive for 
widespread availability. The current shortcomings of available treatments make it critical that we 
understand vital systems within this organism that may lead to development of more effective 
and potentially cheaper medications. DNA polymerase gamma (polG or Mip1p) has been 
identified as the only polymerase in yeast that is capable of replication and repair of the entire 
mitochondrial (mt) genome. In S. cerevisiae, deletion of DNA polG leads to the overall lack of 
mtDNA and the production of petite or wee colonies. C. neoformans is known to be aerobic, and 
therefore, the integrity of its mitochondrial DNA is hypothesized to be vital to the survival of the 
yeast. This necessity of mtDNA replication and maintenance makes polG a strong candidate as a 
potential drug target. Using amino acid sequence homology, a MIP1 homolog has been identified 
in C. neoformans. This gene, CNAG_06769, has a 45% identity to the MIP1 gene in S. 
cerevisiae and contains a mitochondrial localization signal (MLS) as well as a DNA polymerase 
	 x 
A domain, which is found in all known DNA polG proteins.  The polymerase domain identified 
in C. neoformans polG contains a 62% identity and a 76% similarity to the same domain found 
in S. cerevisiae polG. There are also regions within the cryptococcal protein that have previously 
not been seen in other fungal or mammalian polG proteins. This has raised questions regarding 
what the functions of these domains may be and how these functions may be relevant in DNA 
polG research. In this project, RNAi has been used to silence the MIP1 gene (MIP1i).  
Galactose-dependent knock-down of CnMIP1 shows that this gene appears to be essential to C. 
neoformans survival. Growth curves of the MIP1i strains compared to those of wild type cells 
show that the strains are unable to proliferate in the absence of this protein.  In addition, 
mitochondrial integrity assays using the vital dye Mitotracker Green indicate that RNAi of MIP1 
affects the viability of these cells.  Localization of the CnpolG protein with a C-terminal 
mCherry tag was also attempted. Constructs were created to express this protein from its 
endogenous promoter, as well as from a copper-repressible promoter.  However, the attempts to 
localize this protein in vivo have been inconclusive to date and require further optimization. 
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CHAPTER I. INTRODUCTION 
 
A.  The Discovery, Life Cycle, and Significance of Cryptococcus neoformans 
The kingdom Fungi are a diverse group of interesting organisms that is divided into seven 
separate phyla. The two largest groups of this kingdom are put together into the subkingdom 
Dikarya, which is often referred to as the higher fungi. These two groups are known as the 
Basidiomycetes and the Ascomycetes. Basidiomycetes include groups such as mushrooms, 
puffballs, stinkhorns and, mirror yeasts.1 Organisms of this group are filamentous fungi that form 
specialized reproductive cells called basidiospores. These cells form at the end of reproductive 
structures called basidia. During reproduction, basidiospores are often forcibly ejected from the 
basidia allowing for these spores to disperse. Ascomycetes, which are more commonly known as 
the sac fungi, are a large group of fungi that are defined by the presence of an ascus in which 
ascospores are formed. Some members of this group include truffles, and the widely-used 
organism commonly known as baker’s yeast (S. cerevisae).1 
 Cryptococcus neoformans is a basidiomycetous yeast that is identified as being within the 
class Tremellomycetes. This yeast is a single celled organism that replicates via budding, but 
under the correct mating conditions, is capable of producing hyphae with basidiospores at the 
end of its reproductive structures.2 C. neoformans is an opportunistic human pathogenic fungus 
that can be commonly found in the soil throughout the world,3 even within the mountains of 
western North Carolina. It is responsible for the disease cryptococcal meningoencephilitis, which 
is commonly associated with HIV/AIDS infected patients.4 This association occurs because the 
patient’s immune system is greatly suppressed by the viral infection, which allows the yeast to 
successfully evade host immunity, survive, grow, and cause disease. As of 2015, approximately 
40 million people throughout the world were living with HIV/AIDS, and cryptococcal meningitis 
	 2 
was the most common fungal infection found within the central nervous system of these 
patients.5 Cryptococcal infections have also been identified in patients not afflicted with 
HIV/AIDS, but these cases are incredibly rare and involve other immune compromising 
conditions, such as Non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, and organ transplants.6 
 C. neoformans was first discovered by the German pathologist Otto Busse and the 
surgeon Abraham Buschke in 1894.7 When the yeast was first isolated from an infection within a 
lesion found on the tibia of a young woman, these men described it as a Saccharomyces-like 
organism.7 Later that year, the scientist Francesco Sanfelice isolated this same organism from a 
fermenting peach.8 He demonstrated that this yeast was pathogenic in lab animals. Eventually it 
was determined that this organism did not produce ascospores as believed when initially 
discovered; this prevented the organism from being classified as a Saccharomyces.9 The initial 
discovery of C. neoformans in a human patient showed that the yeast was fully capable of 
infecting human hosts, under the correct conditions. It is now well established that this yeast can 
readily infect humans with immune system suppression.  
 Over time, C. neoformans has been called by many different names. It was first called 
Saccharomyces hominis by the German scientist Busse in 1894.7 Later Buschke reviewed this 
organism and the tibial infection in which it was found and determined that it was a coccidium.7 
Next in 1895, Sanfelice named this organism Saccharomyces neoformans. In 1896, the French 
pathologist Curtis described a yeast infection found within the groin of a man that led to a central 
nervous system infection, and named the yeast Megalococcus myxoides. After further testing 
Curtis changed the name of his organism to Saccharomyces subcutaneous tumefaciens. In 1901, 
Vuillemin renamed the organisms that were isolated by Busse and Curtis as Cryptococcus 
hominis, while he renamed Sanfelice’s isolate as Cryptococcus neoformans. This name change 
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was carried out most importantly in order to distinguish these organisms from the ascospore-
forming Saccharomyces. 
Cryptococcus neoformans has now been classified in two separate species, C. 
neoformans (Serotypes A and D) and C. gatti (Serotypes B and C). The four separate serotype 
classifications are based on antigenic differences that were discovered to be present in each. 
These antigenic differences were discovered to be based on differing structural compositions of 
the major capsule polysaccharide, glucuronoxylomannan.13 In addition, the different serotypes 
can be separated by the use of biochemical studies,10 morphological differences within the 
perfect state of the serotypes,11 and by their genetic characteristics.12 In fact, genetic differences 
were used to further separate C. neoformans  into two separate varieties, C. neoformans var. 
grubii (Serotype A) and C. neoformans var. neoformans (Serotype D). The distribution of 
serotype A and serotype D isolates are different from one another, with serotype A being most 
commonly found in most of the world except for northern Europe. Serotype D isolates are most 
often found in temperate climates and are found most often in infections of the skin.14 Serotype D 
strains are also shown to be more susceptible to heat than serotype A cells, which could possibly 
explain why the organism is not found more commonly throughout the globe.15  
C. neoformans contains a number of distinct virulence factors that allow this organism to 
infect mammals and to also evade host defenses organisms, such as humans or mice. The 
presence of a polysaccharide capsule has long been shown to be directly associated with 
virulence in this organism.16 This capsule is composed of long polymers of α-1,3-mannan with 
monosaccharide branches of xylose and glucuronic acid.17 The most current thinking is that this 
polysaccharide capsule exists in order to protect the organism from desiccation in nature, and to 
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reduce the ability of the organism to be ingested and destroyed by soil inhabiting phagocytic 
amoeba, which could be encountered in the yeast’s normal environment.18 
 The first gene that was identified as being critical to the production of the capsule in C. 
neoformans was called CAP59. This gene was identified using random UV mutagenesis and was 
discovered to no longer produce a viable capsule.19 This result was confirmed by using 
homologous recombination to delete CAP59.  The ∆cap59 strains showed an acapsular 
phenotype with dry, wrinkled colonies. Soon after its establishment, the acapsular phenotype was 
directly associated with loss of virulence in murine models. This loss of virulence indicated that 
the capsule was needed for survival and virulence in the mammalian host; a conclusion that was 
supported when complementation of CAP59 restored virulence in mice.19 
There are a number of effects that the capsule has on the host that have been shown to 
contribute to the virulence of the organism. A few of these effects include anti-phagocytosis,20 
complement depletion,21 antibody unresponsiveness,22 high negative charge of cells,23 and 
inhibition of leukocyte migration.24 Combined, all of these factors add up to protect C. 
neoformans from host immunity within humans and other mammals. 
Melanin synthesis is another important virulence factor for C. neoformans’ successful 
host infection. The ability to produce the pigment melanin is unique to C. neoformans in the 
Cryptococcus genus. It is thought that synthesis of melanin using the phenol oxidase enzyme, 
otherwise known as laccase, may have evolved due to the niche that C. neoformans holds in 
nature, in which the yeast decays phenolic compounds found within the wood of various trees.25 
The laccase enzyme is able to metabolize catechol precursors to produce the pigment melanin. 
Two laccase enzymes are encoded within the nuclear genome of C. neoformans.26 The LAC1 
gene encodes a laccase that is the primary producer of cellular melanin, while the LAC2 gene 
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encodes a secondary laccase that appears to play a small role in melanin production.27 This has 
been shown experimentally by the introduction of mutations within LAC1 showing none to very 
little cellular melanin production.28 Deletions of the LAC2 gene, on the other hand, have no 
discernable effect on cellular melanin production.28 Some compounds that can be used as 
substrates for this pathway include epinephrine, nor-epinephrine, L-DOPA, and dopamine. The 
structure of the melanin pigment in C. neoformans is not well understood, but the presence of the 
pigment is believed to assist in virulence in a number of separate but important ways.  These 
include antioxidant activity,29 cell wall integrity,30 cell wall charge,31 protection from high 
temperature by potential dissipation of heat energy,32 and reduction to the effectiveness of some 
common antifungal agents.33 
Other virulence factors associated with C. neoformans include urease production, 
phospholipase production, as well as the ability to grow at 37°C. Urease is a nickel metallo-
enzyme that catalyzes the hydrolysis of urea to ammonia and carbamate. This enzyme allows the 
yeast to respond to pH changes, allowing for survival in seemingly harsh conditions.34 Along 
with harsh pH condition adaptation, the ability to maintain life and to replicate at high 
temperature is another very important factor for the yeast to overcome in order to be capable of 
growing and replicating within a mammalian host.35  
 It was originally discovered that drugs that inhibited the calmodulin-activated serine/ 
threonine-specific phosphatase, known as calcineurin had no effect on C. neoformans at 24°C 
but killed the yeast at 37°C.35 This indicated that calcineurin played a large role in the heat 
tolerance of the organism, and without the use of this pathway the organism could not survive at 
elevated temperatures.35 High temperatures have been shown to reduce transcription of genes 
involved in nucleotide and amino acid biosynthesis.35 There are genes that are specifically 
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induced by the change of temperature within C. neoformans; some of these include trehalose 
synthase, catalase, and superoxide dismutase.36  
B. The Discovery, Function, and Significance of Mitochondria 
 Intracellular structures that resembled what are now known as mitochondria were first 
discovered in the 1840’s. This dates the discovery of mitochondria only a few years after the 
discovery of the nucleus, which was found in 1833.37 In 1890, Altmann was the first individual 
to realize that mitochondria were present ubiquitously in the cells of more than one organism,38 
suggesting that these organelles were very important to the function of many types of cells. He 
termed these structures “bioblasts”. Before the theory of the endosymbiotic origins for 
mitochondria was widely accepted throughout the scientific community, Altmann was convinced 
that mitochondria were “elementary organisms” living within the cell. It is quite interesting to 
realize that Altmann was most likely on the right track with his ideas on how mitochondria may 
have originated. He was convinced that these bioblast’s carried out vital functions within the cell. 
In 1898, an alternative name for these organelles was suggested. The name “mitochondria” was 
proposed because of the organelle’s appearance39; it comes from the Greek words “mitos” 
(meaning thread), and “chondros” (meaning granules).  
 The first discoveries of mitochondrial function were made by Michaelis in 1900, when he 
found that the redox dye Janus Green B functions as a live cell stain for mitochondria.40 Nearly 
half a century later it was shown that the staining of mitochondria by this dye is due to the 
mitochondria’s capacity to oxidize the reduced dye by utilizing the enzyme cytochrome 
oxidase.41 Up to this point, any proposed function of mitochondria was based entirely off of 
observation and not experimentation. Friedrick Meves and Claude Regaud, both scientists 
involved in early mitochondrial research, suggested that the role of mitochondria within the cell 
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could be to “bear genes”.42, 43 This was not an entirely incorrect idea, since it has been found that 
mitochondria do, in fact, contain their own DNA that is separate from nuclear DNA in the cell. 
The confirmation that mitochondria carry out chemical reactions that were most likely essential 
to the organism, opened the door to further research of this organelle. 
 In the 1930’s groundbreaking discoveries led to a great leap in the available knowledge 
about mitochondria. In 1937, Hans Krebs presented his idea of the citric acid cycle in the journal 
Nature.44 This was a very important discovery that brought Krebs much esteem throughout his 
life, and this cycle is now often called the Krebs cycle in his honor. Soon after, Herman Kalckar 
made some initial discoveries into the pathway of aerobic respiration.45 Early work such as these 
studies were later built onto to determine the true function of mitochondria. 
 Mitochondria are now known to be the powerhouse of the cell. This is due to their now 
well-studied role of using simple resources such as glucose to form energy supplies, such as ATP 
and NADH, that can be readily used by the cell. This is carried out within the mitochondria by 
the citric acid cycle and the electron transport chain. Glycolysis is a separate function of the cell 
that takes place within the cytoplasm. Utilizing all of these systems cells can generate, on 
average, 38 molecules of ATP can be generated by a single glucose molecule by aerobic 
respiration - 2 molecules of ATP are generated by glycolysis, 2 molecules of ATP are generated 
by the Krebs cycle, and 34 molecules of ATP are generated by the electron transport chain.46,47,48 
Some energy is lost throughout this process due to the leakiness of the system. The role of 
mitochondria as an energy producer within the cell makes this organelle very important for 
survival and growth, especially within aerobic organisms. Some organisms such as S. cerevisae 
are able to survive on fermentable media without functional mitochondria, but these cells form 
petite colonies that are smaller than the average wild type cell. Other aerobic organisms, such as 
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humans, cannot survive without functioning mitochondria within the cells.  Only anaerobic 
organisms are capable of survival without mitochondria. 
 Mitochondria contain their own unique genome (mtDNA). Mitochondrial DNA in 
human’s codes for 13 protein products, 22 tRNA’s and 2 rRNA’s.49 All of the protein products 
that are coded for by the mitochondria, are involved in the oxidative phosphorylation process.50 
Due to the importance of each aspect of the mtDNA, it is critical that the cell have the means for 
its synthesis and maintenance. Both of these functions are carried out by the protein, DNA 
polymerase Gamma.51 
C. The Discovery, Function, and Significance of DNA Polymerase Gamma (DNA polG) 
DNA polymerase gamma is the only known polymerase to function in the mitochondria 
that is capable of mtDNA replication, proofreading, and maintenance in animals and fungi. It 
was first discovered in 1970 as a polymerase activity isolated from higher eukaryotes, and from 
S. cerevisiae mitochondria that showed aphidicolin-resistance and high sensitivity to ddNTP’s.52, 
53 Mitochondrial fractions taken from the cells of various organisms were used to test for 
polymerase function, and showed a single corresponding activity. DNA polymerase gamma has 
been most highly studied in humans due to the enzymes role in various human diseases. DNA 
polG was believed to be the only mitochondrial DNA polymerase present within human cells, 
until the discovery of Primase polymerase (PrimPol).54 PrimPol is shown to assist in repriming 
of DNA synthesis on stalled replication forks. This function leads to better genomic stability 
within cells. 
DNA polymerase gamma has also been well-studied in S. cerevisiae because it can 
survive without the presence of active mitochondria, which is fatal in many eukaryotes. S. 
cerevisiae colonies devoid of mitochondria, or containing damaged mitochondria, can grow on 
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media that allows for fermentation producing smaller colonies, often referred to as “petite” 
colonies.55 In S. cerevisiae, the absence of the nuclear gene, MIP1, that codes for DNA polG, 
leads to a lack of mitochondrial DNA and ultimately, to a lack of mitochondria.55 Cells devoid of 
mitochondria are no longer able to carry out aerobic respiration, and in many organisms this lack 
of aerobic respiration is fatal. Mutations in this protein have been shown to greatly affect the 
stability of mtDNA in other eukaryotic organisms, such as humans.56 Due to the nuclear origin of 
the MIP1 gene, this sequence contains a mitochondrial localization signal in order to enter the 
mitochondria where its function is carried out.  
 The gene that codes for DNA polG, MIP1, was discovered in a genetic screen for 
temperature sensitive mutants of S. cerevisiae that were able to grow on glycerol at 25°C, but not 
at 36°C.55 It was shown to lack all mitochondrial DNA replication, as well as mitochondrial 
DNA polymerase activity, suggesting that the gene in question was possibly responsible for the 
polymerase activity in the mitochondria.55 MIP1 was located within the genome of S. cerevisiae 
and was identified as being present on chromosome 15, and coded for a protein that was 1254 
amino acids in length.51 Once MIP1 was identified and cloned, the gene was deleted in yeast to 
determine the knockout phenotype. As expected, the resulting mutants were completely lacking 
in mitochondrial DNA.56 
After this enzyme’s function was established, the next step was to determine what 
domains were present in the protein and what they were used for in the cell’s mitochondrial 
replication and repair.  The DNA polG in S. cerevisae has been shown to contain an MLS 
(mitochondrial localization signal), a N-terminus domain, an exonuclease domain, a spacer 
domain, a polymerase domain, and a C-terminal tail.57 These domains have also been shown to 
be present in the protein in other organisms, such as humans.57 Each domain is believed to play a 
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specific role in the synthesis and housekeeping function of the enzyme. The possession of both a 
polymerase domain, as well as an exonuclease domain, suggested this enzyme was fully capable 
of not only DNA synthesis, but also DNA proofreading and DNA maintenance.  
The polymerase domain in DNA polG is responsible for the actual synthesis of mtDNA. 
This domain has been shown to contain three subdomains known as the thumb, palm, and the 
fingers. The function of this region has been studied experimentally by creating three mutations 
in the finger subdomain. These mutations resulted in increases in point mutations as well as 
increased extended mutability.59 This experiment showed that the catalytic domain of the 
enzyme is involved in DNA polymerization as well as fidelity.  
The polymerase domain, when compared to various bacterial DNA polymerases, has 
been shown to belong to the class A family of polymerases. It is highly conserved throughout 
many species such as Homo sapiens, S. cerevisiae, Xenopus laevis, and Rattus norvegicus.60, 61, 
62, 63 Differences in this region do exist between the various species that may lead to processivity 
differences within each enzyme.   
 When the catalytic domain of DNA polG was first purified, an active exonuclease 
domain co-purified with it, indicating that both the polymerase domain as well as the 
exonuclease domain were found in a single polypeptide.5 The exonuclease domain of the enzyme 
is directly responsible for the proofreading capabilities it exhibits. Using alignments to bacterial 
DNA polymerases, three well conserved exonuclease motifs were found in this exonuclease 
domain. Single mutations were carried out in each sub-domain in order to determine the 
associated phenotypes.64 The mutations greatly decreased the effectiveness of the proofreading 
capabilities of the DNA polG enzyme.64 Soon after, a mouse model completely lacking in polG 
exonuclease activity was created.65 This exonuclease devoid DNA polG had astounding effects 
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on the mice. Errors within the mtDNA of the mice increased, early onset aging was observed as 
the lifespan of the mice was decreased.65 This suggests that exonuclease function is vital to 
prevent premature aging. 
The spacer region in between the polymerase and exonuclease domains (Figure 5) is 
hypothesized to be directly involved in the proper folding of the enzyme, as well as the binding 
site for accessory subunits.66 In the human DNA polG dimeric accessory subunits bind to the 
catalytic subunit of the enzyme,67 in Drosophila  melanogaster the accessory subunit is 
monomeric, in S. cerevisiae an accessory protein is not present.68,69 This suggests that S. 
cerevisiae carries out the function of this accessory subunit using other methods. The spacer 
region of the enzyme, although not catalytically functional itself, is known to be responsible for 
disease when mutated in the human enzyme.57 The specific mutation G737R, has been linked to 
Alpers, Myocerebrohepatopathy and other Infantile syndromes caused by mtDNA depletion.57 
The C-terminal tail of DNA polymerase gamma varies greatly in length between species. 
It is directly involved in the polymerization of DNA strands and appears to play a role in strand 
displacement during DNA synthesis within S. cerevisiae.58 In S. cerevisiae, the presence of the 
longer, and functional C-terminal tail may prevent the enzyme from requiring the accessory 
subunits that are required in other species. This is predicted because this domain functions as a 
DNA helicase during DNA synthesis.68 Experimentally this has been shown by the deletion of 
the last 216 residues of the domain. Many of the residues in this region are highly conserved, and 
when they are deleted the mutability of the polymerase function of the enzyme increases 
dramatically.58 The deletion of the same 216 amino acids appears to have no effect on 
exonuclease activity of the enzyme.58 In the presence of low concentrations of dNTP’s the strand 
displacement function of the enzyme appears to be reduced approximately by half.70 In C. 
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neoformans a much shorter C-terminal tail is present (Figure 5) , this indicates that accessory 
subunits are most likely required for DNA synthesis in this organism, as in humans. 
Several accessory proteins are directly involved in the replication, and repair that is 
carried out by DNA polG. These include, mitochondrial single stranded binding protein, 
mitochondrial helicase, RNase H1, topoisomerases, DNA ligase III, and other proteins and 
transcription factors.71 The mitochondrial single stranded binding protein (mtSSB) has been 
shown to enhance helix destabilization for the associated DNA helicases, and polG.72 This 
function directly supports mitochondrial DNA replication, and repair in vivo.  In D. 
melanogaster, the presence of mtSSB has be shown to increase mitochondrial DNA synthesis by 
around 40-fold.73 Mutations in this protein have also been shown to cause significant decreases 
in mitochondrial DNA synthesis.72 
The ATP dependent mitochondrial helicase TWINKLE, has been shown to be directly 
involved in mtDNA maintenance and regulation of the amount of total mitochondrial DNA 
present within mammals.74 TWINKLE colocalizes with mtDNA in vivo, and contains a 5’ to 3’ 
helicase domain. Overexpression of TWINKLE in murine models has shown an increase in 
overall mtDNA copy numbers present within a cell, while a reduction is TWINKLE lowers the 
amount of mtDNA present.74 These studies suggest that TWINKLE plays a significant role in the 
maintenance of copy numbers of mitochondrial DNA that are present within each cell. 
Certain RNase's, as well as topoisomerases are also present in mitochondrial DNA 
synthesis and repair within the cell.71 RNase H1is a cellular RNase that is found in high copy 
numbers within the nucleus, but is also found in much lower numbers to be present in the 
mitochondria. It is hypothesized that this enzyme plays a role in mtDNA synthesis by the 
removal of RNA primers during DNA replication.75 Topoisomerases such as Topo I and 
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TopoIII∝ have been shown to be present in the mitochondria. These enzymes are believed to 
relax and remove supercoils that are present due to the activity of the mitochondrial helicase.76 
In this project, I have identified the DNA polymerase gamma encoding gene in C. 
neoformans, CnMIP1. The polG product encoded for by CnMIP1 is highly conserved to the polG 
found in S. cerevisiae and humans, although it has novel domains that are unique to the C. 
neoformans protein (see Discussion). I have shown that this gene is essential to the survival of 
Cryptococcus neoformans and have tried to localize the protein in the cell. 
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CHAPTER II.  MATERIALS AND METHODS 
 
A. Strains Used 
The KN99 matα (Serotype A) strain was used for all of the mCherry localization 
experiments. The Neomycin resistance gene (NEOR) is found within the construct in order to 
select for transformed colonies. 
The JEC21 (Serotype D) strain was used for all RNAi experiments as both the source 
material for genomic inserts of targeted genes and for the RNAi vector transformations and 
growth assays. 
The JEC43 (ura5) strain was used for GFP construct expression using URA5 as a 
selectable marker. This strain is unable to synthesize the essential amino acid uracil. 
B. Media and Growth Conditions 
 All C. neoformans strains were maintained in YPD media (1% yeast extract, 2% tryptone, 
and 2% dextrose) at 30˚C. For selection of specific transformants, YPD media was supplemented 
with the antifungal drug neomycin (Geneticin or G418, Fisher BioReagents #BP673) at 
100µg/ml.  
Media that is lacking the amino acid uracil was used for selection of transformation 
colonies that contained the URA5 selectable marker. This media was made using a –uracil 
dropout mix (US Biological) that contains all of the essential amino acids except for uracil. 
All biolistic transformations were carried out on YPD plates containing 1M sorbitol 
before transferring to the appropriate selective medium for growth. 
Bacterial cultures were grown in LB broth media (0.5% yeast extract, 1% tryptone, and 
1% NaCl). Agar plates containing LB media supplemented with 100µg/mL ampicillin or 
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kanamycin were used as appropriate for selection of cells containing the desired plasmid 
constructs. SOC media (2% vegetable peptone, 0.5% yeast extract, 10mM NaCl, 2.5mM KCl, 
10mM MgCl2, 10mM MgSO4, 20mM Glucose; NewEngland BioLabs INC. #B9020S) was used 
for outgrowth during bacterial transformations. 
Cells were tested for RNAi on YPG (1% yeast extract, 2% tryptone, and 2% galactose) 
media supplemented with the drug Geneticin with and without 5-fluoroorotic acid (5-FOA) at 
1mg/ml on plates, and 1mg/ml or 0.2mg/ml in liquid media. 
C. Identification of the MIP1 Gene Sequence within Cryptococcus neoformans 
 The identification of the sequence of the MIP1 sequence in Cryptococcus neoformans 
was carried out utilizing the online genomic sequence database FungiDB (FungiDB.org).  
 Protein sequence comparisons were carried out between DNA polymerase Gamma of 
humans, S. cerevisiae, and C. neoformans, using the online software Clustal 
Omega(https://www.ebi.ac.uk/Tools/msa/clustalo/). 
D. Genomic DNA Preparation 
 Genomic DNA was prepared using the method described by Bose et al.76 Briefly, 3mls of 
cells were grown overnight in YPD media at 30°C and were harvested by centrifugation at ∼ 
12,000g. The cells were lysed in 0.5ml extraction buffer (50mM Tris-HCL, pH 8; 20mM EDTA; 
1% SDS) by bead beating the cells using a vortex mixer or bead beater on high speed for 2 
minute intervals, letting the cells rest on ice for 1 minute in between. This process was repeated 
until approximately 50-80% breakage was obtained, as determined by light microscopy. The 
samples were then incubated at 70°C for 10 minutes, vortexed well, and treated with 200µl 5M 
potassium acetate and 150µl 5M NaCl. Samples were mixed by inversion, incubated on ice for 
20 minutes, and then centrifuged at 14,500rpm for 20 minutes. Supernatant from each sample 
	 16 
was transferred to a clean tube. 450µl chloroform was added and the samples were centrifuged 
for 10 minutes at 14,500 rpm. The aqueous phase was transferred to a new tube with 200µl of 
PEG 8000. Samples were incubated on ice for 10 minutes, before being centrifuged for 10 
minutes. Supernatant was removed from each sample and discarded. Each pellet was re-
suspended in 50µl sterile water. The supernatant from the samples were treated with 1µl 
500µg/ml RNase and incubated at 37°C for 30 minutes to remove RNA from the samples. A 
1/10th volume of 3M sodium acetate (5µl), and 3 volumes of ethanol (150µl) were added to each 
sample. Samples placed in -20°C for 30 minutes, and centrifuged at 14,500rpm for 10 minutes at 
4°C. The supernatant was removed from each sample and the pellet was resuspended in 50µl 
sterile water. 
E. Making the MIP1 RNAi (MIP1i) plasmid 
i. pIBB103 plasmid 
The pIBB103 RNAi vector (see Figure 1) was used for making the MIP1i (MIP1 RNAi) 
construct. The plasmid contains a bacterial origin of replication, an ampicillinR gene for selection 
in bacteria, and a NEOR gene for selection in yeast on the drug G418. This plasmid has an RNAi 
cassette that contains two GAL7 promoters coding in opposite directions that are flanked by 
terminators, functionally creating dsRNA when active. Between the promoters, a ura5 segment 
is present for URA5 RNAi, which assists with 5-FOA selection. 
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Figure 1. pIBB103 vector used for MIP1 RNAi. 
 
ii. Cloning exonic portion of MIP1 into the pIBB103 RNAi vector using SLIC 
A PCR reaction was carried out to amplify bases 697-956 of the MIP1gene that is part of 
the third exon. This reaction was performed using BLO163 as the forward primer, BLO164 
as the reverse primer (see Table 1), and genomic DNA from JEC21 (Serotype D) as the 
template. The reaction mix for this PCR reaction contained 1µl template DNA, 5µl Q5 
reaction buffer, 0.5µl dNTP’s, 1.5µl 10µM BLO163, 1.5µl 10µM BLO164, 0.75µl DMSO, 
0.3µl Q5® High-Fidelity polymerase, and 14.5µl water. The reaction conditions used were 
98ºC 30s; 30 x (98ºC 10s, 57ºC 30s, 72ºC 2:30m); 72ºC 2m. The PCR product obtained from 
this reaction was column purified. The pIBB103 plasmid (see Figure 1.) was linearized with 
SpeI, incubated at 37°C for 5h. The SpeI digest contained 15µl pIBB103 plasmid DNA, 6µl 
10xCutsmartTM buffer, 32µl water, and 2µl SpeI restriction enzyme in a total reaction volume 
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of 60 µl. The linearized pIBB103 from the SpeI digest was column purified using the 
Wizard® SV Gel and PCR Clean-up System (Promega) following the manufacturer 
instruction, and resuspended in 50µl of water. 
A SLIC,78 (Sequence and Ligation Independent Cloning) cloning reaction was set up in 
order to place the mip1 insert within pIBB103. The SLIC reaction contained 1µl NEB buffer 
2, 1µl SpeI-digested pIBB103 DNA, 1µl or 0µl mip1 DNA, in a final volume of 10µl with 
water. These SLIC reactions were incubated with 0.25µl T4 DNA polymerase added and 
reacted for 20 minutes at room temperature. Ligation was carried out by endogenous E. coli 
repair enzymes. Transformation was carried out with 2.5µl SLIC reactions into 50µl of 
competent E. coli and plated onto LB plates containing 100µg/ml ampicillin.  
iii. Cloning the MIP1 exon into pIBB103 using T4 DNA Ligase 
 Due to the failure of SLIC cloning, the PCR amplified mip1 fragment from E (ii) 
was cloned into the pJET1.2 vector. The CloneJET® PCR cloning kit (Thermo Fischer) was 
used as instructed by the manufacturer to blunt and then to also ligate the MIP1 insert into 
the pJET 1.2 vector. A SpeI restriction digest was performed to remove the mip1 fragment 
from the pJET1.2 plasmid. This reaction contained 15µl pJET1.2-mip1 DNA, 6µl 
10xCutsmartTM buffer, 36µl water, and 3µl SpeI enzyme in a total volume of 60µl. pIBB103 
was digested with SpeI enzyme as above. Both digested samples were column purified using 
the Wizard® Plus SV DNA cleanup kit (Promega) according to the manufacturers instruction 
and resuspended in 50µl water. The linearized pIBB103 was treated with Calf intestinal 
alkaline phosphatase (CIAP), which removed the phosphate group from the 5’ ends of its 
DNA, in order to prevent self-ligation.  
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Three ligation reactions were carried out to place the mip1 fragment within the pIBB103 
RNAi vector. The ligation reactions contained 4.5µl pIBB103, with 0µl, 2µl, or 3µl purified 
mip1 PCR fragment, 2µl T4 DNA ligase buffer, 1µl of T4 DNA ligase, and the reaction 
volume was brought up to 20µl with water. Each reaction was incubated for 45 minutes at 
room temperature, and 4µl of each ligation reaction was transformed into 30µl of competent 
E. coli cells. These transformations were plated on LB plates that contained 100µg/ml 
ampicillin, and allowed to grow overnight at 37ºC.  
Eight colonies from each experimental plate were grown overnight in LB +AMP broth 
and plasmid DNA mini preps were performed for each using the Wizard® Plus SV Minprep 
kit (Promega) following the manufacturer’s instructions. The plasmid DNA was resuspended 
in 75µl water. A SpeI restriction digest was performed to confirm the correct cloning of mip1 
into the pIBB103 vector. This reaction contained 4ul pIBB103 mip1 DNA, 1.5µl CutsmartTM 
buffer, 8.5µl water and 1µl SpeI enzyme in a total reaction volume of 15µl.  
F. Making the MIP1-mCherry NEOR plasmid 
The MIP1-mCherry construct was made in the pLK25 plasmid that contains a bacterial 
origin of replication, an ampicillinR gene for selection within bacteria, and a NEOR gene for 
selection in yeast (see Figure 2). The mCherry fluorescent protein-coding gene is present within 
this plasmid directly downstream of an XbaI restriction site. 
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Figure 2. pLK25 vector used for MIP1 localization. 
 
The endogenous MIP1 gene along with its promoter (562bp of 5’ DNA) was PCR 
amplified from KN99 matα (IBCN2) genomic DNA using the primers BLO144 and BLO 145 
(see Table 1). This reaction contained 32.5µl dH20, 10µl Phusion HF 5x buffer, 2.5µl 10µM 
BLO144, 2.5ul 10µM BLO145, 1µl dNTP’s, 0.5µl Phusion® Taq polymerase, and 1µl KN99 
matα genomic DNA as template. The conditions of this PCR reaction were 98ºC 30s; 30 x (98ºC 
10s, 58ºC 10s, 72ºC 3:00m); 72ºC 5m.  The products of this PCR reaction were column purified 
using the Wizard® SV Gel and PCR Clean-up System (Promega) following the manufacturer 
instruction, and resuspended in 50µl of water.  
The CloneJET® PCR cloning kit (Thermo Fischer) was used according to the 
manufacturer’s instructions to blunt, and then ligate the MIP1 insert into the pJET1.2 vector. 7µl 
of ligation mixture was transformed into 40µl of high efficiency competent E. coli cells, plated 
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onto LB plates containing 100µg/ml ampicillin, and allowed to grow overnight at 37°C. Seven 
colonies were inoculated into LB +AMP broth and grown at 37°C overnight with aeration.  
Plasmid mini preps were made with 1.5mls of each culture using the Wizard® Plus SV Minprep 
kit (Promega) and resuspended in 75µl water. DNA from each mini prep was digested using 4µl 
pJET1.2-MIP1 plasmid DNA, 1.5µl CutsmartTM buffer, 8.5µl water, and 1µl XbaI enzyme in a 
total reaction volume of 15µl. PCR reactions were performed on each mini prep DNA using 
primers WBO1 and WBO5 (see Table 1) to further confirm the presence of the MIP1 gene in the 
plasmid. The reaction mix contained 12.5µl 2x Taq Mastermix (Promega), 1ul 10µM WBO1, 
1µl 10µM WBO5, 0.75µl DMSO, and 9.75µl water. The conditions of the PCR reaction were 
94ºC 1m; 30 x (94ºC 15s, 60ºC 30s, 72ºC 2:30m); 72ºC 10m.  
The MIP1 gene along with its promoter was removed from the pJET 1.2 plasmid by XbaI 
restriction digest. The reaction contained 20µl MIP1-pJET 1.2, 6µl CutsmartTM buffer, 31µl 
water, and 3µl XbaI enzyme in a total reaction volume of 60µl. The insert was gel purified using 
the Wizard® Plus SV DNA cleanup kit (Promega) and resuspended in 50µl water.  pLK25 (see 
Figure 2.) was linearized using 15µl pLK25 plasmid DNA, 5µl CutsmartTM buffer, 28µl water, 
and 2µl XbaI enzyme in a 50µl total reaction volume. XbaI was heat inactivated at 65°C for 
20min, and 1µl CIAP was added to the reaction. The reaction was incubated at 37°C for 1 hour.  
Three ligation reactions were prepared to clone MIP1 into pLK25. These ligations 
contained 2µl pLK25 plasmid DNA, 2µl T4 DNA ligase buffer, 1µl T4 DNA ligase, and 0µl, 
2µl, or 4µl MIP1 insert in a final volume of 20µl with water. The ligations were incubated at 
room temperature for 2 hours, and 4µl of the ligation mixture was transformed into 40µl high 
efficiency competent E. coli cells. These transformants were plated onto LB plates with 
100µg/ml ampicillin.  
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To check for the presence of MIP1 and promoter in the pLK25 vector a PCR reaction 
using the forward primer WBO1 and the reverse primer WBO5 (see Table 1) was carried out as 
in F (i). A BglII digest was performed on the plasmid in order to determine the orientation in 
which the gene was cloned into the plasmid. This digest was carried out using 4µl pLK25-MIP1 
plasmid DNA, 1.5µl 10XCutsmartTM buffer, 1µl BglII enzyme, in a final volume of 15µl with 
water.  
G. Making the CTR4p-MIP1-mCherry (NEOR) Plasmid 
The CTR4 promoter from the pCTR4-2 plasmid (pIBB236) was amplified by PCR using 
primers BLO171 and BLO172 (see Table 1). The PCR reaction contained 1µl pCTR4-2p plasmid 
template, 5µl Q5 reaction buffer, 0.5µl dNTP’s, 1.5µl 10µM BLO171, 1.5ul 10µM BLO 172, 
0.75µl DMSO, 0.3µl Q5® High-Fidelity polymerase (NEB), and 14.5µl water. The 
thermocycling conditions were as follows: 98ºC 30s; 30 x (98ºC 10s, 67ºC 30s, 72ºC 60s); 72ºC 
2m.  
25µl pLK25 plasmid DNA was digested using 2µl XbaI in 60µl final volume, column 
purified using the Wizard® Plus SV DNA cleanup kit (Promega), and resuspended in 50µl 
water.  The purified CTR4 promoter fragment was cloned into the XbaI site of pLK25 vector 
using NEBuilder® Hifi DNA Assembly (NEB). The Hifi ligation reaction contained 1:3 vector: 
insert (2.1µl pLK25, 0.3µl CTR4p) DNA, 10µl Hifi MM, and 7.6µl water. A negative control 
reaction was performed and contained 2.1µl pLK25, 0µl CTR4p, 10µl Hifi MM, and 7.9µl water. 
The ligations were incubated at 50ºC for 15 minutes. 2µl Hifi reactions were transformed into 
50µl high efficiency competent E. coli. The transformants were plated on LB plates 
with100µg/ml ampicillin. Since the AvrII site is contained within the forward primer and is part 
of the PCR fragment, plasmid DNA from 10 transformants were digested with AvrII to confirm 
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the presence of the insert. The reaction mixture contained 4µl miniprep DNA, 1.5µl CutsmartTM 
buffer, 9µl water and 0.5µl AvrII in a total reaction volume of 15µl.  
After CTR4p had been cloned into pLK25, the MIP1 gene was cloned downstream of the 
promoter. A PCR amplification reaction was used to amplify MIP1 from KN99 matα genomic 
DNA using the primers BLO179 and BLO180 which contain overlaps to the CTR4p-pLK25 
vector sequence for Hifi cloning. The reaction mix for this PCR contained 10µl Q5 reaction 
buffer, 3µl 10µM BLO179, 3µl 10µM BLO180, 1.5µl DMSO, 1µl dNTP’s, 2µl Q5® High-
Fidelity polymerase, 29µl water, and 1µl KN99 matα genomic DNA as the template. The 
conditions for thermocycling were 98ºC 30s; 30 x (98ºC 10s, 58ºC 30s, 72ºC 2:30m); 72ºC 2m. 
An AvrII digest was carried out in order to linearize the pLK25-CTR4p plasmid, and prepare it 
for MIP1 cloning. Both the MIP1 amplicon, as well as the AvrII digested pLK25-CTR4p were 
column purified using the Wizard® Plus SV Miniprep kit (Promega) and resuspended in 50µl 
water.  
NEBuilder® Hifi DNA Assembly (NEB) technology was used to insert place the MIP1 
gene in the pLK25-CTR4p plasmid, in frame with the mCherry tag.  The Hifi ligations contained 
1:3 molar ratio of vector: insert DNA with1.5µl CTR4-pLK25, 1.13µl or no MIP1 PCR 
fragment, 10µl Hifi master mix, in a total reaction volume of 20µl with water. Both ligation 
reactions were incubated at 50ºC for 15 minutes. Transformations were carried out by placing 
2µl of Hifi ligation mixes into 45µl of competent E. coli cells. Transformations were plated onto 
LB plates with 100µg/ml ampicillin, and grown overnight at 37°C.  Plasmids from eight colonies 
were used to PCR amplify the MIP1 gene. The reaction mix contained 5µl Q5 reaction buffer, 
0.5µl dNTP’s, 1.5µl 10µM BLO179, 1.5µl 10µM BLO180, 0.75µl DMSO, 0.3µl Q5® High-
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Fidelity polymerase, 1µl plasmid prep DNA, and 14.5µl Water. The reaction conditions were 
identical to the previous MIP1 amplification using these primers.  
H. Making the pGPDp-MIP1-GFP Plasmid 
The MIP1 ORF gene containing overlaps for Hifi cloning into the pGPDp-GFP vector 
was PCR amplified. The reaction mix for this PCR contained 5µl Q5 reaction buffer, 0.75µl of 
dNTP’s, 1.5µl 10µM BLO 191, 1.5µl 10µM BLO 192, 0.5µl Q5® High-Fidelity polymerase, 
13.65µl water, and 1µl KN99 matα genomic DNA as template. The reaction conditions used 
were 98ºC 30s; 30 x (98ºC 10s, 62ºC 30s, 72ºC 2:30m); 72ºC 2m. The pGPDp-GFP vector was 
linearized using the restriction enzyme EcoRI in a reaction mix containing10ul GPD-GFP vector, 
4µl 10XFastDigestTM buffer, 24µl water, and 2µl EcoRI enzyme in a total volume of 40µl. This 
reaction was incubated at 37 ºC for 6 hours. The digested pGPDp-GFP and the amplified MIP1 
were column purified using the Wizard® Plus SV DNA cleanup kit (Promega) and resuspended 
in 50µl water. 
The MIP1 fragment was ligated into the linearized pGPDp-GFP plasmid as follows. Two 
ligation reactions were performed in order to place MIP1 into the plasmid. The reactions 
contained 5µl pGPDp-GFP vector, 1.1µl, or no MIP1, 10µl Hifi master mix, and each reaction 
was brought up to a total volume of 20µl with water. Both reactions were incubated at 50 ºC for 
15 minutes. Transformations of the Hifi ligations were carried out by placing 2µl of each ligation 
into 50µl of competent E. coli. Transformations were grown on LB plates containing 100µg/ml 
ampicillin overnight at 37°C. Eight colonies were selected from the experimental plate and 
inoculated into LB+AMP broth. Minipreps were performed on the eight cultures using the 
Wizard® Plus SV Minprep kit (Promega) and resuspended in 75µl water. MIP1 was confirmed 
by using PCR amplification using BLO191 and BLO192 as previously described. 
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I. Transforming C. neoformans by Electroporation 
 Electroporation mediated transformation of C. neoformans was carried out as follows. 
Strains to be transformed were cultured in approximately 25ml of appropriate media and allowed 
to grow overnight at 30°C with shaking at 180rpm. After 16-18h of growth, this culture was 
diluted to approximately 5 x 106 cells/ml with the appropriate media and allowed to grow for an 
additional 4 hours. The culture was centrifuged at 4,000rpm in an Eppendorf MiniSpinTM 
centrifuge, and washed twice with 50ml sterile DI water in order to remove any excess media, 
and once with electroporation buffer (10mM Tris-HCl, pH7.5, 1mM MgCl2, 270mM sucrose). 
The samples were then treated with 200µl of 1M DTT in 50ml of electroporation buffer, and 
incubated for 10 minutes on ice. The culture was washed with electroporation buffer as above. 
The supernatant was discarded and the pelleted cells were resuspended in the residual buffer. 
Then 60µl of this mix was placed into a 0.2cm electroporation cuvette. The appropriate DNA 
was added to this culture and electroporation is carried out with the settings of 0.5kV, 25µF, and 
either 1000 or ∞ ohms. Pulse length or time constants of 15-25msec gave the best results. 
Samples were resuspended in YPD broth for 2 hours before plating on appropriate selection 
media. 
i. Electroporation of JEC21 cells with the pIBB103-MIP1 (MIP1i) construct 
pIBB103-MIP1 was linearized with I-SceI. This reaction contained 25µl pIBB103-MIP1, 
6µl 10XCutsmartTM buffer, 27.5µl water and 1.5µl I-SceI enzyme in a total reaction volume of 
60µl. This linearized DNA was purified using the Wizard® Plus SV DNA cleanup kit 
(Promega), and resuspended in 50µl water. Electroporation was carried out using 6µl pIBB103-
MIP1 and 60µl of JEC21(Serotype D) cells. A negative control was performed by 
electroporation of 60µl JEC21 cells with no DNA. The time constants for the +DNA reactions 
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ranged from 31ms to 142ms. The time constants for the –DNA reactions were 28ms to 81ms. 
These reactions were both plated onto YPD-NEO plates and allowed to grow for 4 days at 30ºC.  
ii. Electroporation of KN99 matα cells with the pLK25-MIP1 or pLK25-CTR4p-MIP1 
constructs 
Linearization of pLK25-MIP1 or pLK25-CTR4p-MIP1 was performed using the 
restriction enzyme NotI. The reaction contained 20ul plasmid DNA. 6ul 10xNEB 3.1TM buffer, 
32ul water, and 2ul NotI enzyme in a total reaction volume of 60ul. This linearized DNA was 
column purified and resuspended in 50ul water. Electroporation was carried out using 4ul 
pLK25-MIP1 or 6ul pLK25-CTR4p-MIP1 in 60ul of KN99α cells. Negative controls were 
performed by electroporation of 60ul KN99α cells with no DNA. The time constants for the 
+DNA reactions ranged from 47ms to 118ms and 71ms to 128ms, respectively. The time 
constants for the –DNA reactions ranged from 21ms to 89ms and 43ms to 71ms, respectively. 
These reactions were both plated onto YPD-NEO plates and allowed to grow for 4 days at 30ºC. 
YPD/Neo broth containing 200µM bathocuproine disulfonic acid (BCS) (Sigma-Aldrich) 
and CuSO4 at concentrations of 25µM and 50µM were made to test CTR4p-MIP1 transformants. 
J. Biolistic Transformation 
In order to stably integrate a DNA construct into the genomic DNA of C. neoformans 
biolistic incorporation was utilized. Biolistic incorporation was carried out using the method 
described by Bose et al.76 All biolistic transformations were carried out on YPD plates 
containing 1M sorbitol before transferring the cells to the appropriate selective medium. 
 Briefly, the method described requires the binding of the desired DNA construct onto 
golden beads. These beads are then placed onto a disc and compressed helium is used to launch 
the DNA bound beads into the C. neoformans culture that is evenly spread across a YPD-1M-
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Sorbitol plate. Once biolistics is carried out the cells are allowed to grow for 4-6 hours and then 
scraped from the YPD plate and spread onto plates containing the appropriate selective media for 
the selection of transformed colonies. 
K. Growth Curves 
Colonies were allowed to grow overnight at 30°C in appropriate liquid media. Each 
culture was divided in two and centrifuged for 3m at 14,500rpm. One half of each culture was 
washed three times with sterile PBS and re-suspended in 30ml of YPG-NEO, the other half of 
each culture was re-suspended in 30ml of YPD-NEO. After 3h each sample that contained YPG-
NEO was spun down and resuspended into YPG-NEO broth that contained 5-FOA 
(concentrations given with each experiment). At the time points 0h, 3h, 6h, 9h, 12h, and 24h 2ml 
of each sample was collected, and fixed in 3.5% formaldehyde. Absorbance at 600nm was used 
to determine culture density for each sample. 
i. Determination of effective 5-FOA levels in growth curves 
To determine an appropriate level of 5-FOA that will select for robust RNAi but not be 
toxic to all cells in liquid culture, a growth curve was performed using various levels of 5-FOA. 
This experiment was carried out using the protocol for growth curves described previously (see 
Methods K), adding 5-FOA levels that were 0.0, 0.125, 0.250, and 0.5mg/ml at the 3h point. 
Samples were taken at 6h and 24h for growth analysis. 
L. MitotrackerTM Green Live Cell Assay 
 The following assay was designed to determine the mitochondrial integrity of cells under 
varying growth conditions. Cells that were grown under varying conditions were incubated in 
500µl sterile PBS containing 0.2µM Mitotracker green live cell dye, covered with foil, and 
incubated with shaking at 30 ºC. The cells were then centrifuged at 13,400 rpm for 5 minutes, 
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washed 3 times with 500 µl of sterile PBS, and resuspended in 200µl sterile PBS. 10µl of each 
sample was placed on a clean glass slide for imaging, two images were taken for each sample. 
For this work each image was taken using the EVOSTM FL Auto microscope in the 
biology department at WCU, using the GFP light cube (395 wavelength). Each image was saved 
using the settings of 79 light intensity, and 73 exposure, and 0 gain. All images were taken using 
the 40X objective. Quantification of light intensity within pictures was carried out by taking an 
81nm area of centralized regions within 15 separate cells selected at random and using the 
measure function within imageJ to obtain an average fluorescent light intensity within the area 
selected. The value produced from each of the 15 cells measured were averaged together, 
producing a single value that represented the fluorescent intensity of all cells within the image. 
Average background was subtracted within each image by selecting 15 random points of 81nm 
throughout the image that did not contain a cell, and using the measure function to determine the 
intensity of fluorescence within these points. The intensity of each of these 15 points were 
averaged together, and subtracted from the overall average value of light intensity collected from 
cells within the same image. This value represented the average fluorescent intensity of cells 
within an image that had been adjusted for background fluorescence. 
M. Deconvolution of MitotrackerTM Stained Images 
Image deconvolution was performed in FIJI using the Iterative Deconvolve 3D plugin.80 This 
plugin is partially based on the DAMAS algorithm by Thomas F. Brooks and William M. 
Humphreys, Jr., NASA-Langley Research Center. The settings used included an anti-ringing 
step, low pass filter (x,y,z) set to 1.0, and 10-15 iterations. 
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N. Primers Used 
Table 1. Primers used in this project 
Name	 Description	 Sequence	(5’	to	3’)	 Amplicon	
Length	
(bp)	
Restriction	
Enzyme	
BLO144	 CnMIP1	F	 cccaaatctagaCAATATGAGTGTGTAGCCAG	 5075	 XbaI	
BLO145	 CnMIP1	R	 cccaaatctagaTTGAAACTTCTTGCTAGAA	 5075	 XbaI	
BLO179	 CnMIP1	F	 gacaacgacttcaccaatccATGCGCAAGGCGCTTGATATTTC	 4513	 NA	
BLO180	 CnMIP1	R	 ctcgcccttgctcaccattcTTGAAACTTCTTGCTAGAAGACAGAAC	 4513	 NA	
BLO191	 CnMIP1F	 atacttgcataaatacaatgaattctATGCGCAAGGCGCTTGATATTTC	 4513	 NA	
BLO192	 CnMIP1	R	 gctcctcacccttggacatgaattcttTTGAAACTTCTTGCTAGAAGACAGAAC	 4513	 NA	
BLO163	 MIP1	SpeI	
F	
TTTACTAGTcaagctctcttggatatctc	 259	 SpeI	
BLO164	 MIP1	SpeI	
R	
TTTACTAGTcatctgaatagtacttggtc	 259	 SpeI	
WBO1	 Exon	1	F	
(MIP1)	
ATGCGCAAGGCGCTTGATATTTC	 281	 NA	
WBO5	 Exon	1	R	
(MIP1)	
GGATTTGCGAATCTTCCTAACTCGAGGCTGGCCATAGC	 281	 NA	
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CHAPTER III. RESULTS 
 
A. Identifying C. neoformans MIP1 Gene by Sequence Homology 
DNA polymerase gamma (DNA polG) has been studied extensively in S. cerevisiae, and 
humans, but not in C. neoformans.  Since C. neoformans is an aerobic organism, we 
hypothesized that DNA polG will be essential to mitochondrial function, and ultimately the 
survival of the organism.  Therefore, to better understand this function in C. neoformans, the 
presence of this gene(s) in the cryptococcal genome was determined. A BLAST search of the 
H99 Serotype A, as well as JEC21 Serotype D genome against the S. cerevisiae DNA polG 
protein sequence identified one gene (CNAG_06769) in C. neoformans with a high 
probability of encoding this enzyme (Figure 3). The gene showed a 45% identity, and a 58% 
similarity between the amino acid sequences within Serotype A (Figure S1). Only one MIP1 
homolog was found in C. neoformans. In order to determine if Primase polymerase was 
present within C. neoformans a BLAST search of the same C. neoformans genomes against 
the human PrimPol protein sequence identified no homologs within C. neoformans. 
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Figure 3. Amino acid BLAST search comparing the C. neoformans genome against the S. 
cerevisiae DNA polG sequence. 
 
 
 Several conserved protein domains are present in the putative C. neoformans DNA 
polymerase gamma protein shown in Figure 4, that are also present within the S. cerevisiae 
protein. Alignment between the polymerase domain of S. cerevisiae, and C. neoformans shows a 
62% identity and 76% similarity between the species. Both proteins also contain contain a MLS. 
The high sequence similarity to S. cerevisiae DNA polG (ScpolG), as well as the presence of a 
conserved polymerase domain suggests that CNAG_06769 gene in C. neoformans encodes the 
DNA polymerase gamma protein. However, there are certain domains that differ between the 
DNA polG proteins in the two species. Two domains of unknown function are present within the 
C. neoformans protein, while S. cerevisiae has a much longer C terminal extension (Figure 5). 
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Figure 4. Presence of conserved domains within the DNA polymerase gamma homolog found 
within C. neoformans. 
 
 
 
Figure 5. Domain alignment of DNA polG amino acid sequences from human (top), S. cerevisiae 
(middle), and C. neoformans (bottom). This alignment was created using domain predictions 
from the National Center of Biotechnology Information’s online BLAST database. 
 
 
 The two domains of unknown function that have been identified within C. neoformans 
appear to be unique to this organism. BLAST searches reveal no homologous domains within 
DNA polG of other known organisms. Function of these regions of the protein is unknown. 
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B. Determining the Essentiality of DNA Polymerase Gamma in C. neoformans by 
RNA Interference 
Since C. neoformans is an obligate aerobic organism, we hypothesized that this yeast will 
require active mitochondria in order to survive and be virulent. The presence of a functional 
DNA polymerase gamma is known to be essential for the mitochondria within a cell to function 
properly. In order to test if DNA polG is required for survival in C. neoformans the CnMip1 
mRNA and protein levels were knocked down in vivo using RNA interference. 
RNAi is a process that leads to degradation of mRNA that corresponds to the sequence of 
double stranded RNA found within the cell.  In order to check the essentiality of CnMIP1 in C. 
neoformans, bases 697-956 of the CnMIP1 gene was cloned into the RNAi vector, pIBB103 
(Figure 1). The RNAi cassette in pIBB103 contains two galactose inducible promoters that 
transcribe from opposing ends of a DNA fragment and are flanked by terminators. This allows 
for the transcription of sense and antisense RNA to occur, functionally creating dsRNA within 
the cell.  Within these opposing promoters and terminators is a portion of the ura5 gene, which 
assists in selection on 5-FOA containing media. A SpeI restriction endonuclease site in between 
the GAL7 promoters allows for cloning of selected sequence into the RNAi construct, in order 
for the associated gene to be knocked down in vivo. There are also telomeric regions found 
within the plasmid that assist with stability of the vector within yeast hosts. 
 Utilizing primers BLO163, and BLO164 (see Table 1), a 562bp portion of the third exon of 
the CnMIP1 gene, was PCR amplified using genomic DNA from the JEC21 (Serotype D) strain 
as the template. An attempt to use SLIC cloning to clone the PCR amplified exonic 
mip1fragment was unsuccessful, therefore T4 DNA ligase was used. The PCR amplified exonic 
mip1 fragment was cloned in the SpeI site of pIBB103. Figure 6(b) shows the results of the SpeI 
digest used to confirm the presence of the mip1 fragment in four different transformants. The 
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restriction digest confirmed that all four selected transformants contained the correct pIBB103-
mip1 construct. The 8504bp band present at the top of figure 6 (b) correlates to the pIBB103 
vector, while the 259bp band correlates to the mip1 fragment.   
 
 
Figure 6. (a) Structure of pIBB103-mip1 plasmid. (b) SpeI digest of pIBB103-mip1 
transformants. (1- 4 are plasmid digests from four pIBB103-mip1 colonies; L=1kb Generuler 
DNA ladder). 
 
The pIBB103-mip1 #2 along with the empty pIBB103 vector without an insert were 
electroporated into the JEC21 strain. Transformants were selected by plating on YPG-NEO 
plates. The JEC21 strain was used for this step due to the efficiency of the GAL7 promoter being 
higher than in a Serotype A strain like KN99.20 Transformants streaked onto YPG-NEO (see 
Methods) were replica plated onto YPG-NEO containing 5-FOA in order to select for cells that 
are performing RNAi robustly. Figure 7 shows the results of replica plating these colonies from 
YPG-NEO to YPG-NEO containing 5-FOA. The colonies containing the mip1 RNAi showed 
decreased growth in 5-FOA media, while the empty pIBB103 vector grew as on YPG-NEO. 
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Figure 7. Replica plate of pIBB103-mip1 (top) and pIBB103-empty (bottom) from YPG-NEO 
onto YPG-NEO containing 5-FOA. 
 
C. Growth of Cells When MIP1 Gene Product is Decreased 
i. Growth of cells within YPD-NEO or YPG-NEO containing 1mg/ml 5-FOA 
To determine the effect of the pIBB103-mip1 construct on the survival and growth of 
transformed colonies, three colonies containing the pIBB103-mip1 plasmid, and one colony 
containing the empty pIBB103 plasmid were grown overnight in YPD-NEO media. After 
overnight growth at 30°C these cultures were divided with one half remaining in YPD-NEO 
media, while the other half of the culture was centrifuged and resuspended with YPG-NEO 
media. At the 3hour time point the cultures containing YPG-NEO media were centrifuged 
and re-suspended with YPG-NEO media containing 1mg/ml 5-FOA. Aliquots of 2mls were 
collected at different time points, and culture densities were determined 
spectrophotometerically. The results were normalized and are shown in Figure 8. 
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Figure 8. OD600 readings of cells containing either the pIBB103-mip1 construct, or the pIBB103 
construct. Time points (in hours) of sample collection are indicated. Broken lines indicate 
presence of YPG-NEO media, solid lines indicate presence of YPD-NEO media. 1mg/ml 5-FOA 
was added to all YPG-NEO cultures at the 3h time point. [Standard deviation used for error 
bars]. 
 
Although all cultures grew well in YPD-NEO as expected, they all grew poorly in YPG-NEO 
media containing 1mg/ml 5-FOA. This was initially puzzling, since pIBB103 cells appear to 
grow on YPG-NEO plates with 1mg/ml 5-FOA (Figure 7). However, I hypothesized that this 
result was likely because the level of 5-FOA was toxic for cells to survive in liquid culture, even 
when robust RNAi of the ura5 fragment was occurring.  
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ii. Growth of cells within YPD-NEO or YPG-NEO containing 0.2mg/ml 5-FOA 
Since the previous experiment showed that the media likely contained levels of 5-FOA that 
were too high for cell growth, the above growth curve was repeated using two colonies 
containing pIBB103, and 3 colonies containing pIBB103-mip1, and 0.0, 0.125, 0.25, and 
0.5mg/ml 5-FOA. Samples were taken for growth analysis at the 6h and 24h time points. The 
0.125mg/ml 5-FOA was not able to inhibit growth well, while 5-FOA concentrations of 
0.5mg/ml 5-FOA and above appeared to be toxic to all cells in liquid culture (Figure 9). 
However, the 0.25mg/ml 5-FOA appeared to be better tolerated by the cells with the pIBB103 
plasmid. Therefore, the growth curve was repeated using two colonies that contained the 
pIBB103-mip1 vector, and two colonies that contained the pIBB103 empty vector with 0.2mg/ml 
5-FOA being added at the 3h time point (Figure 10).  
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Figure 9. OD600 readings of cells containing either the pIBB103-mip1 construct, or the pIBB103 
construct. Cells containing either construct were grown for 24 hours in levels of 5-FOA that 
varied from 0, 0.125, 0.25, or 0.5mg/ml 5-FOA, as indicated in the figure legend. 5-FOA was 
added at the 3h time point for in all cultures. [Standard deviation used for error bars]. 
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Figure 10. OD600 readings of cells containing either the pIBB103-mip1 construct, or the 
pIBB103 construct. Time points (in hours) of sample collection are indicated. Broken lines 
indicate presence of YPG-NEO media, solid lines indicate presence of YPD-NEO media. 
0.2mg/ml 5-FOA was added to all YPG-NEO cultures at the 3h time point. [Standard deviation 
used for error bars]. 
 
The data shown in Figure 10 indicates that colonies containing pIBB103 are able to grow in 
YPG-NEO media containing 0.2mg/ml 5-FOA, but those with pIBB103-MIP1 that are actively 
silencing MIP1 are unable to do so over 24 hours in the same media. All colonies grew well 
within YPD-NEO media. 
 
D. Effect of MIP1p Depletion on Mitochondrial Stability 
 Although the RNAi studies demonstrated that the CnMIP1 gene is essential for growth, it 
did not give any indication of the gene’s function. The MIP1 gene is known to affect 
mitochondrial function in other organisms. Therefore, to determine the effects of a reduction of 
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Mip1p on the state of the cells’ mitochondria, cells with reduced MIP1 mRNA (MIP1i) were 
stained with the Mitotracker Green live cell dye. This dye stains active mitochondria and is used 
to give an indication of mitochondrial function within each cell. We hypothesized that because 
MIP1 mRNA was decreased in the presence of the pIBB103-mip1 RNAi construct, 
mitochondrial stability would be lower than wild type, causing a loss of cell viability. As a result, 
mitochondria would no longer be able to take up the Mitotracker dye, as it would in a live cell.  
i. Development of the Mitochondrial Stability Assay 
In order to determine the mitochondrial stability in cells grown under varied conditions, an 
assay was developed that could show differences within mitochondria of the cells being studied. 
The mitochondria of wild type cells fluoresce brightly and fairly ubiquitously when treated with 
0.2µM Mitotracker green dye for 30 minutes as shown in Figure 11. Cells transformed with 
pIBB103 were used as a positive control to identify if mitochondrial integrity was intact after 
incubation of cells in YPG-NEO media containing 1mg/ml 5-FOA, cells were transformed and 
grown as mentioned previously (see Methods L) and were incubated in sterile PBS containing 
0.2µM Mitotracker green live cell dye.  Different number of PBS washes were tried in order to 
obtain best results. Similarly, different light settings were tried till the best results were obtained 
with the settings mentioned in the Methods. 
The number of brightly fluorescent cells in different cultures was not the best representation 
of the data since there were many cells with lower fluorescence in a culture. In order to get the 
best representation, I decided to quantify the average fluorescence of 15 cells found within each 
image. Once stained cells were imaged and processed as described within the methods it was 
determined that this assay was capable of showing differences in fluorescent intensity between 
colonies that did or did not contain polG. 
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Figure 11. (a)Wild type JEC21 cell stained with 0.2µM MitotrackerTM Green live cell dye for 
30 minutes. (b) Wild type JEC21cells stained with 0.2µM MitotrackerTM Green for 30 minutes. 
Scale bar is equal to 20µm. 
 
ii. Mitochondrial stability is decreased in cells grown on YPGal-NEO plates 
 Three colonies containing the pIBB103-mip1 plasmid, and one colony containing the 
empty pIBB103 plasmid were grown overnight in YPG-NEO media. These colonies were treated 
and imaged as described in the methods. These images were used to determine the levels of 
fluorescence emitted by the cells in each sample.  
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Figure 12. (a) Average levels of fluorescence emitted by cells containing either the pIBB103-
mip1 construct, or the pIBB103 construct. Presence of 5-FOA within solution is indicated above. 
(b) Flow chart briefly describing the experiment shown in Figure 12(a). [Standard deviation used 
for error bars]. 
 
The results shown in Figure 12 show that the mitochondria at time 0h had lower 
fluorescence intensity in the MIP1i colonies than the pIBB103 control. Fluorescence levels were 
consistently higher for pIBB103 colonies until the 12hour time point. Fluorescence levels were 
higher within the pIBB103 and pIBB103-mip1 cells at the 6hours time, compared to the 3h time 
for an unknown reason. 
 
iii. Growing cells from YPD-NEO that were previously not induced for RNAi 
The previous experiment showed that growth of pIBB103-mip1 cells on YPG-NEO 
plates after transformation was affecting the mitochondria, presumably by knocking down MIP1 
in many of the cells. Therefore, I tested whether growing the cells on YPD-NEO plates after 
transformation, and in YPD-NEO broth overnight would prevent this effect. Three colonies 
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containing the pIBB103-mip1 plasmid, and two colonies containing the empty pIBB103 plasmid 
were grown overnight in YPD-NEO media and transferred to YPG-NEO media at 0h (Figure 
13b). Average levels of fluorescence are shown in Figure 13a below. 
 
 
Figure 13. (a) Levels of fluorescence emitted by cells containing either the pIBB103-mip1 
construct, or the pIBB103 construct. Presence of 5-FOA within solution is indicated above. (b) 
Flow chart briefly describing the experiment carried out to produce the graph shown in figure 
13(a). [Standard deviation used for error bars]. 
 
Growing cells in dextrose containing media prevented RNAi from occurring before the start 
of the experiment. As a result, fluorescence levels were higher in the pIBB103 (this should not 
affect cell with empty vector) containing cells throughout the 24hour incubation time, with levels 
of fluorescence being lower in colonies actively silencing MIP1. After the 6h time point all 
transformed cells began to show decreased fluorescence.  
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E. Efforts to Localize Fluorescently Tagged DNA Polymerase Gamma 
In order to localize the Mip1p protein in vivo, a DNA construct was designed to express it 
from its endogenous promoter in-frame with a C-terminal mCherry fluorescent protein 
(Figure 2). This allows for the MIP1 product to be followed in vivo using fluorescent 
microscopy.  
The MIP1 gene with 562bp of upstream sequence was PCR amplified from KN99 mat α 
genomic DNA. The product of this PCR reaction is shown in Figure 14(a). Once amplified 
this product was cloned into the pJET1.2 subcloning vector. Confirmation of the cloning of 
MIP1 into the pJET1.2 vector, was done by restriction digestion using XbaI. As seen in 
Figure 14b the XbaI digest yielded two bands matching the sizes of pJET 1.2 (2974bp) as 
well as MIP1 (5075bp). This MIP1 gene was removed from the pJET1.2 vector and inserted 
into the mCherry containing pLK25 vector (Figure 2). Six colonies from the transformation 
were tested for the presence of the MIP1 gene insert by PCR amplification of the third exon 
of MIP1. Figure 15 shows that one of these colonies (#2) gave a product for the PCR and 
contains the MIP1 insert. 
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Figure 14. (a) Product of PCR reaction carried out in order to amplify the MIP1 gene along with 
the genes endogenous promoter from KN99∝ genomic DNA. (- indicates the negative control 
within the reaction. + indicates the PCR reaction containing MIP1 along with 562bp of upstream 
DNA). (b) Restriction digest of plasmid DNA using XbaI that contains MIP1 cloned within the 
pJET 1.2 cloning vector. The product of two bands that are 2793bp and 5075bp, confirms that 
MIP1 was successfully cloned into the vector. 
 
Figure 15. MIP1 first exon PCR amplification using plasmid DNA from 6 colonies transformed 
by the pLK25-MIP1 ligation reaction. The numbers 1-6 correspond to the colony from which the 
PCR template originated. The - corresponds to the negative control in the PCR. L contains an 
NEB 1kb ladder. 
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Electroporation, and biolistic incorporation of the pLK25-MIP1 construct into the 
KN99α strain of C. neoformans was carried out as described within the methods in order to 
determine the localization of Mip1p in vivo. Cells transformed via electroporation, and 
biolistic incorporation were prepared for viewing by growing cells in rich media overnight 
(YPD), and transferring cells to minimal media for 4 hours before viewing in order to reduce 
background fluorescence. Once prepared, cells were viewed for mCherry fluorescence, but 
appeared to not produce any fluorescent signal in most of the cells visualized. A minority of 
cells did produce signal, but numbers of cells, as well as fluorescence levels were too low to 
be definitive.  
F. CnMIP1 Expressed from a Regulatable Promoter 
Due to the lack of consistent signal from cells containing the pLK25-MIP1 construct 
described above, the CTR4 inducible/repressible promoter was used in order to overexpress the 
Mip1p-mCherry protein in vivo. Overexpression of the fluorescent conjugate protein may allow 
for visualization of the protein that may be expressed at quantities too low for us to detect.  
The CTR4 promoter was PCR amplified with primers that contained overlapping sequence in 
the pLK25 mCherry plasmid, and inserted into the pLK25 vector linearized with XbaI upstream 
of the mCherry gene by NEB Hifi cloning. Ten transformants were tested in order to verify the 
correct ligation of the two fragments. An AvrII restriction digest was used to check the plasmids 
for the presence of the CTR4 promoter, since this enzyme site was absent in the original pLK25 
plasmid, but was present in the reverse primer (BLO172) that was used to amplify the CTR4 
promoter fragment. This method showed that colonies which had been linearized contained the 
CTR4 promoter due to an AvrII restriction site within the primers as seen in Figure 16. Three 
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colonies appear to contain the CTR4p in pLK25 allowing for MIP1 to be cloned behind the 
CTR4p and upstream of the mCherry fluorescent tag. 
 
 
Figure 16.  Results of restriction digest carried out on plasmid DNA from 10 colonies potentially 
transformed with the pLK25-CTR4p construct using the restriction enzyme AvrII. A single linear 
band in transformants 1-3 indicates that the CTR4p fragment is found within the vector. 
 
 The pLK25-CTR4p #2 construct was linearized by AvrII. The MIP1 gene was PCR 
amplified using primers containing overlapping regions with the pLK25-CTR4p plasmid, and 
cloned into the plasmid. Four bacterial transformants were tested by PCR for the presence of 
MIP1. Three of the transformants appeared to contain an insert of the correct size (Figure 17). 
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Figure 17. PCR confirmation of the presence of MIP1 within the pLK25-CTR4p construct. A 
band present at 4513bp shows a positive result, indicating that MIP1 is in fact present within the 
construct. - indicates the negative control within the reaction. 
 
Electroporation, and biolistic incorporation of pLK25-CTR4p-MIP1 into the KN99α strain of 
C. neoformans was carried out to determine the localization of MIP1 along with its mCherry tag 
in vivo, expressed from the copper repressible CTR4 promoter. Cells containing the pLK25-
CTR4p-MIP1plasmid were grown overnight in YPD-NEO media, and transferred to minimal 
media containing 200µm BCS for 4 h before viewing in order induce expression of the Mip1p-
mCherry fusion protein of the MIP1-mCherry fusion protein. Unfortunately, overexpression of 
Mip1-mCherry did not yield good signal. As with expression from the endogenous promoter, a 
small minority of cells that were viewed did produce signal, but numbers of cells, as well as 
fluorescence levels were very low.
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CHAPTER IV.  Discussion 
 
A. Identifying the C. neoformans MIP1 Gene by Sequence Homology 
 Through amino acid alignment, the putative C. neoformans DNA polymerase gamma, 
encoded by the gene CNAG_06769, was seen to be highly conserved, with high identity to polG 
enzymes found in S. cerevisiae and humans (Figure 1 and Figure S1). Although polG is highly 
conserved between C. neoformans and S. cerevisiae, there are some differences that can be 
determined from domain alignments between the organisms. DNA polG in S. cerevisiae contains 
a C-terminal tail that is longer, by approximately 200 residues, then the C-terminal tail found in 
the C. neoformans or the human proteins.81 The C. neoformans polG has two regions (residues 1-
135) and (residues 742-934), which are not present in any other polG protein that has been 
previously characterized (Figure 5). RNA seq data from multiple laboratories (Figure 18) shows 
that mRNA incorporating these “spacer” regions is produced under multiple growth conditions, 
suggesting that they are, in fact, part of the mature protein. The functions of these two spacer 
regions are unknown, but present an exciting opportunity for further study, and characterization. 
Due to the pathogenic nature of C. neoformans, these unknown domains could potentially be 
used as a drug target that can distinguish the protein found within C. neoformans from DNA 
polG found in humans, during infection. 
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B. Determining the Essentiality of DNA Polymerase Gamma to the Survival of C. 
neoformans 
 RNA interference targeted to a small portion of the third exon of MIP1 suggests that 
DNA polG is essential to C. neoformans. Negative selection with 5-FOA was used to test for the 
robust action of the RNAi system in transformed cells. The URA5 gene encodes the enzyme 
orotidine 5’- phosphate decarboxylase (ODCase), which catalyzes a reaction in the synthesis of 
the essential amino acid uracil. If cells with a functional URA5 gene are grown on media 
containing 5-FOA, the action of ODCase, produces the compound 5-fluorouracil, which is toxic 
to the cell, and cause cell death.  In the absence of URA5 expression, such as in a Δura5 strain or 
if RNAi efficiently silences URA5, ODCase is not able to utilize 5-FOA to produce 5-
fluorouracil, allowing cells to survive and grow on uracil supplemented media.82 This has been 
utilized to determine the essentiality of a second gene on 5-FOA. 
Negative selection on YPG-NEO plates containing 1mg/ml 5-FOA, as well as growth in 
liquid media containing 0.2mg/ml 5-FOA showed that colonies that contained the MIP1i 
construct did not grow on galactose containing media with 5-FOA present. Colonies that 
contained the empty vector were able to grow on this media. pIBB103 empty vector colonies 
growing in the presence of 5-FOA shows that the vector was carrying out RNAi of the URA5 
gene successfully. Cells that are only silencing URA5 survived 5-FOA selection, but cells 
silencing MIP1 as well did not survive, which indicates that the silencing of the MIP1 gene is 
responsible for cell death. This result suggests that MIP1 is essential for survival in C. 
neoformans. 
Analysis of growth curves suggested that knockdown of the MIP1 gene in vivo was sufficient 
to greatly reduce the growth of C. neoformans when in YPG-NEO media containing 0.2mg/ml 5-
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FOA. Cells that contained the pIBB103-mip1 construct did not grow in galactose containing 
media with 5-FOA present. Colonies that contained the same vector without the mip1 fragment 
were able to grow on galactose containing media with 5-FOA present, although they replicated 
less successfully than when grown within YPD-NEO media. This decrease of growth within 5-
FOA is likely due to the RNAi vector not silencing URA5 efficiently enough to survive in some 
cells. RNAi is known to be a process that is not always efficient, and levels of RNA interference 
can greatly vary between cells.83 This likely allows some cells to be capable of survival while 
others simply cannot carry out RNAi efficiently enough to survive. 
C. neoformans is an aerobic organism that should need mitochondria to survive.84 The 
knockdown of DNA polG appears to be sufficient to destroy the function of cellular 
mitochondria and kill these cells. The protein encoded by CNAG_06769 has been shown to have 
DNA polymerase activity (Wallen, personal communication). This result corresponds to previous 
research that has shown in other organisms, such as S. cerevisiae, that DNA polG is essential to 
the integrity of cellular mitochondria,57 and therefore is likely essential for survival under aerobic 
conditions. 
C. Mitochondrial Staining of Cells in the Absence of MIP1 
Using MitoTracker Green staining, it was determined that cells containing the pIBB103-mip1 
construct, that were grown overnight in YPG-NEO broth, had a lower fluorescence signal at the 
start of the experiment than cells containing the pIBB103 empty construct. This result suggests 
that MIP1 RNAi was likely occurring before the experiment began due to the presence of 
galactose in the media. Throughout the 24h incubation period colonies containing pIBB103 
showed higher fluorescence than colonies containing pIBB103-mip1. This result led to another 
mitochondrial integrity experiment in which all colonies were grown in media containing only 
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dextrose until the experiment had begun. Dextrose prevents induction of the RNAi machinery 
within the cell,76 and should stop RNAi from occurring before the experiment began. 
 Cells imaged after being grown overnight in YPD-NEO media showed similar 
fluorescence at the start of the experiment in colonies that contained pIBB103 or pIBB103-mip1. 
This indicated that the lack of galactose in the media during overnight growth, and therefore an 
absence of RNAi, allowed the mitochondrial stability to be uniform in all cultures at the 
beginning of the experiment. pIBB103 containing colonies showed higher fluorescent emission 
throughout the experiment than colonies containing pIBB103-mip1. All colonies showed lower 
signal after the 6hour time point. The level of fluorescence being higher within colonies that 
contained the pIBB103 empty vector suggests that MIP1i is destructive to mitochondrial stability 
within C. neoformans.  
D. Localization of Mip1p 
 The KN99 mat α (Serotype A) strain of C. neoformans was transformed with the 
pLK25-MIP1 plasmid in order to express the MIP1 protein product along with an mCherry 
fusion protein. Once the cells containing this plasmid were treated and viewed (as described in 
the methods) pictures were processed using imageJ, and it was determined that no signal was 
present within the majority of cells transformed with this plasmid. A minority of transformed 
cells showed faint signal, indicating that some cells may contain the MIP1-mCherry fusion 
protein. The signal’s presence not being found within all cells indicates that the protein may be 
expressed at levels too low to view in the majority of cells, or that the majority of cells were 
simply not expressing the protein. Another option to explain the lack of signal present within 
most cells is that the protein may be quickly degraded after being expressed, resulting in a low or 
absence of signal present within samples. Western blots have not yet been performed to confirm 
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the presence of the fusion protein in the cell. In order to test if protein levels were too low to 
visualize, another construct was made containing the MIP1 gene under a copper 
inducible/repressible promoter, using the same pLK25 plasmid. Under the CTR4 promoter DNA 
polymerase gamma can be overexpressed within the cell,79 this will give an indication of whether 
the protein is being expressed highly enough to visualize, within the cell. 
The KN99 mat α (Serotype A) strain of C. neoformans was transformed with the pLK25-
CTR4p-MIP1 plasmid in order to induce/repress expression of the MIP1 protein product along 
with an mCherry fusion protein. Cells containing this plasmid were treated with 200µm BCS and 
were imaged as described within the methods. Cells transformed with pLK25-CTR4p-MIP1 
showed very similar fluorescence to the cells transformed with pLK25-MIP1. A minority of 
transformed cells showed faint signal, indicating that some cells may contain the MIP1-mCherry 
fusion protein. This result suggested that low levels of protein expression were likely not the 
cause of low fluorescence within the pLK25-MIP1 transformed cells. The low level of 
fluorescence present within transformed cells may be due to degradation of the protein, or that 
high levels of the polymerase are toxic within the cell. Western blots have not yet been 
performed to confirm the presence of the fusion protein in the cell. Due to the possibility of the 
mCherry protein being degraded within the cell, a new construct was designed using a GFP 
protein that had been codon optimized for expression within C. neoformans.  
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E. Future Directions 
i. Localizing MIP1 using C. neoformans codon optimized mEGFP 
Due to failure of previous attempts to localize CnpolG using an mCherry tag, a plasmid 
containing the C. neoformans GPD promoter upstream of the codon optimized EGFP gene have 
been obtained. In future this plasmid will continue to be used for the creation of a MIP1-GFP 
fusion protein that can be expressed within C. neoformans, and used to determine the in vivo 
localization of the corresponding protein. The use of a fluorescent protein that has been codon 
optimized for use within this organism should help create a fusion protein that will be stably 
maintained, and not degraded within the cell. 
ii. Replacement of the endogenous promoter with the CTR4 copper inducible promoter 
within the genome of C. neoformans 
To further confirm the essentiality of MIP1 within C. neoformans the endogenous MIP1 
promoter will be replaced with the CTR4 copper inducible promoter within the genome. This 
will be carried out by creating a CTR4p-MIP1-mCherry construct that contains 3’ and 5’ 
sequence that is homologous to the surrounding genomic DNA in the cell. Using the homology 
of this construct to the surrounding area of the wild type gene, homologous recombination will 
be used to replace the endogenous MIP1 gene along with its promoter within the cell. This will 
allow the expression of the MIP1 gene in vivo to be effectively turned off, using the copper 
inducible promoter, effectively showing a MIP1 knockout phenotype within C. neoformans. This 
experiment should further confirm the effect of MIP1 depletion in C. neoformans. 
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Figure 18. RNA seq data from multiple laboratories showing the production of mRNA from the 
CnMIP1 gene. This data was collected from FungiDB.com. Black arrows indicate introns within 
the CnMIP1 gene. 
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iii. Activity of CnpolG and study of its domains 
Work is currently being carried out to determine the wild type activity of DNA polymerase 
gamma within C. neoformans (Wallen, direct communication). With the activity of the wild type 
protein established, biochemical techniques can be used to determine what role portions of the 
unknown regions within the protein play within the proper folding, or function of CnpolG. Due 
to the CnpolG enzyme containing a short c-terminal tail compared to ScpolG, it will be 
interesting to determine if the unknown domains function to bind accessory proteins that are 
needed for DNA synthesis, or repair. Biochemical studies involving specific deletions and even 
substitutions will reveal insight on how the protein functions within this organism, and what 
differences exist between the DNA polymerase gamma within C. neoformans, compared to those 
of S. cerevisiae or humans. If significant differences within the proteins can be discovered these 
regions could be used as potential drug targets for use in treatment of Cryptococcal 
meningoencephilitis in humans. Cheaper drugs with less detrimental side effects could possibly 
be designed using this information, allowing a more widespread availability to drugs of this 
nature. 
 A better understanding of the DNA polG protein could also assist with forming a better 
understanding of polG associated disease in humans. Many specific residues are currently known 
to be directly linked with specific diseases in humans, and more are sure to be identified in the 
future. Studies within yeast models could provide insight into potential disease associated 
regions that have not yet been studied within other higher eukaryotes. 
 
 
 
	 57 
REFERENCES 
 1. Webster J, Weber R. Introduction to Fungi, Third Edition.09/01/2007. Cambridge University 
Press. 
2. Lengeler KB, Cox GM, Heitman J. 2001. Serotype AD Strains of Cryptococcus neoformans 
Are Diploid or Aneuploid and Are Heterozygous at the Mating-Type Locus. Petri WA, ed. 
Infection and Immunity. 69(1):115-122. 
3. Callejas A, Ordonez N, Rodriguez MC, Castaneda E. 1998. First isolation of Cryptococcus 
neoformans var. gattii, serotype C, from the environment in Colombia. Med. Mycol. 36:341–44 
4. Mamidi, A., DeSimone, J.A. & Pomerantz, R.J. 2002. Central nervous system infections in 
individuals with HIV-1 infection. Journal of Neuro Virology. 8: 158. 
5. Del Valle L, Piña-Oviedo S. 2006. HIV disorders of the brain: pathology and pathogenesis. 
Front Biosci. 1; 11:718-732. 
6. Kontoyiannis D, Peitsch W, Reddy B, Whimbey E, Han X, Bodey G, Rolston K. 2001.  
Cryptococcosis in Patients with Cancer. Clinical Infectious Diseases. Volume 32, Issue 11. 145-
150. 
7. Busse O. Uber parasitare Zelleinschlusse und ihre Zuchtung. Centralbl. Bakt. Parasit. 1894;16 
8. Sanfelice F. Contributo alla morfologia e biologia dei blastomiceti che si sviluppano nei 
succhi de alcuni frutti. Ann. Ist. Ig. R. Univ. Roma. 1894; 4:463–469. 
9. Barnett JA. A history of research on yeasts 14: medical yeasts part 2, Cryptococcus 
neoformans. Yeast. 2010; 27:875–904. 
10. Bennett JE, Kwon-Chung KJ, Theodore TS. 1978. Biochemical differences between 
serotypes of Cryptococcus neoformans. Sabouraudia 16(3):167-74. 
11. Kwon-Chung KJ. 1975. A new genus, Filobasidiella, the perfect state of Cryptococcus 
neoformans. Mycologia.67:1197–1200. 
	 58 
12. Know-Chung K. 1978. A new species of Filobasidella, the sexual state of Cryptococcus 
neoformans B and C serotypes. Mycologia. 68(4):943-6. 
13. Bennett J E, Kwon-Chung K J, Howard D H. 1977. Epidemiologic differences among 
serotypes of Cryptococcus neoformans. Am J Epidemiol.105:582–586. 
14. Dromer F, Mathoulin S, Dupont B, Letenneur L, Ronin O. 1996. Individual and 
environmental factors associated with infection due to Cryptococcus neoformans serotype D. 
Clin. Infect Dis. 23:91–96. 
15. Martinez L, Garcia-Rivera, Casadevall A. 2001. Cryptococcus neoformans var. neoformans 
(Serotype D) Strains Are More Susceptible to Heat than C. neoformans var. grubii (Serotype A) 
Strains. J Clin. Microbiol. 39(9): 3365–3367. 
16. Bolaños, B., and T. G. Mitchell. 1989. Phagocytosis of Cryptococcus neoformans by rat 
alveolar macrophages. J. Med. Vet. Mycol. 27:203-217. 
17. Cherniak R, Sundstrom J. 1994. Polysaccharide antigens of the capsule of Cryptococcus 
neoformans. Infection and Immunity. 62(5):1507-1512. 
18. Casadevall A. 2012. Amoeba Provide Insight into the Origin of Virulence in Pathogenic 
Fungi. In: Mylonakis E., Ausubel F., Gilmore M., Casadevall A. (eds) Recent Advances on 
Model Hosts. Advances in Experimental Medicine and Biology, vol 710. Springer, New York, 
NY 
19. Chang, Y. C., and K. J. Kwon-Chung. 1994. Complementation of a capsule-deficient 
mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:4912-4919. 
20. Kozel T. R. 1977. Non-encapsulated variant of Cryptococcus neoformans. II. Surface 
receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by 
polysaccharide. Infect. Immun. 16, 99–106 
	 59 
21. Macher A, Bennett J, Gadek J, Frank M. 1978. Complement Depletion in Cryptococcal 
Sepsis. The Journal of Immunology. 120 (5) 1686-1690. 
22. Kozel T, Gulley W, Cazin J. 1997. Immune response to Cryptococcus neoformans soluble 
polysaccharide: immunological unresponsiveness. Infection and Immunity. 18;3 701-707. 
23. Nosanchuk J, Casadeball A. 1997. Cellular charge of Cryptococcus neoformans: 
contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. 
Infection and immunity. 65;5 1836-1841. 
24. Vecchiarelli A, Retini C, Pietrella D, et al. 1995. Downregulation by cryptococcal 
polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human 
monocytes. Infection and Immunity. 63(8):2919-2923. 
25. Callejas A, Ordonez N, Rodriguez MC, Castaneda E. 1998. First isolation of Cryptococcus 
neoformans var. gattii, serotype C, from the environment in Colombia. Med. Mycol. 36:341–44 
26. Missall T, Moran J, Corbett J, Lodge J. 2005. Distinct stress responses of tow functional 
laccases in Cryptococcus neoformans are revealed in the absence of the thiol-specific antioxidant 
Tsa1. Eukaryot. Cell. 4:202-208. 
27. 16. Zhu Xudong, Williamson P. 2004. Role of laccase in the biology and virulence of 
Cryptococcus neoformans. FEMS Yeast Research. 5;1. 1-10. 
28. 76. Salas, S.D., Bennett, J.E., Kwon-Chung, K.J., Perfect, J.R., Williamson, P.R. 1996. 
Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J. Exp. Med 184, 
377–386. 
29. Wang Y, Casadevall A. 1995. Cryptococcus neoformans melanin and virulence: mechanism 
of action. Infection and immunity. 63;8 3131-3136. 
	 60 
30. Wang Y, Aisen P, Casadevall A. 1996. Melanin, melanin “ghosts,” and melanin composition 
in Cryptococcus neoformans. Infection and immunity. 64;7 2420-2424. 
31. Nosanchuk J, Casadeball A. 1997. Cellular charge of Cryptococcus neoformans: 
contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. 
Infection and immunity, 65;5 1836-1841. 
32. Rosas A, Casadevall A. 1997. Melanization affects susceptibility of Cryptococcus 
neoformans to heat and cold, FEMS Microbiology Letters, Volume 153, Issue 2, 1 Pages 265–
272 
33. Wang Y, Casadevall A. 1994. Growth of Cryptococcus neoformans in presence of L-dopa 
decreases its susceptibility to amphotericin B. Antimicrob. Agents Chemother.  38;11 2648-
2650. 
34. Cox, G. M, Cole G, Perfect J. Identification of and disruption of the Cryptococcus 
neoformans urease gene, abst 1.6:150. 3rd International Conference on Cryptococcus and 
Cryptococcosis, Paris. 
35. Odom A, Muir S, Lim E, Toffaletti DL, Perfect J, Heitman J. 1997. Calcineurin is required 
for virulence of Cryptococcus neoformans. The EMBO Journal. 16(10):2576-2589.  
36. Rodrigues M, Nakayasu E, Oliveira D, et al. 2008. Extracellular Vesicles Produced by 
Cryptococcus neoformans Contain Protein Components Associated with Virulence. Eukaryotic 
Cell. 7(1):58-67. 
37. Brown, R. 1833. Observations on the organs and the mode of fecundation in Orchidae and 
Asclepiadeae. Trans. Linn. Soc. 16: 685-745 
38. Altmann, R. 1890. Die Elementarorganismen und ihre Beziehungen zu den Zellen. Veit, 
Leipzig. 
	 61 
39. Benda C 1898. Ueber die spermatogenese der vertebraten und höherer evertebraten, II. Theil: 
Die histiogenese der spermien. Arch Anat Physiol 73: 393–398 
40. Michaelis, L. 1900. Arch. Mikrosk. Anal. 55:558-575 
41. Lazarow, A., and S. J. Cooperstein. 1953. J. Histochem. Cylochem.1:234-241 
42. Meves, F. 1908. Arch. Mikrosk. Anal.72 :816-867 
43. Regaud, C. 1909. C.R. Soc. Biol. 66:1034-1036. 
44. Krebs, H.A., and W. A. Johnson. 1937. Biochem. J. 31 :645-660 
45. Kalckar, H. 1937. Enzymologia. 2 :47-52. 
46. Berg JM, Tymoczko JL, Stryer L. 2002. Biochemistry. 5th edition. New York: W H 
Freeman; Chapter 17, The Citric Acid Cycle. Available from: 
47. Alberts B, Johnson A, Lewis J, et al. 2002. Molecular Biology of the Cell. 4th edition. New 
York: Garland Science. Electron-Transport Chains and Their Proton Pumps.  
48. Berg JM, Tymoczko JL, Stryer L. Biochemistry. 5th edition. New York: W H Freeman; 
2002. Section 16.1, Glycolysis Is an Energy-Conversion Pathway in Many Organisms.  
49. Anderson S, Bankier A, Barrell  B, Bruijn M, Coulson A, Drouin J. 1981. Sequence and 
organization of the human mitochondrial genome. Nature 290, 457-465.  
50. Taanman J. 1999. The mitochondrial genome: structure, transcription, translation and 
replicaton. BBA, Bioenergetics. 1410, 2. 103-123. 
51. Foury F. 1989. Cloning and sequencing of the nuclear gene MIP1 encoding the catalytic 
subunit of the yeast mitochondrial DNA polymerase. J. Biol. Chem. 264, 20552–20560. 
52. Wintersberger U, Wintersberger E. 1970. Studies on deoxyribonucleic acid polymerases 
from yeast. 2. Partial purification and characterization of mitochondrial DNA polymerase from 
wild type and respiration-deficient yeast cells. European Journal of Biochemistry. 13(1):20-27 
	 62 
53. Wintersberger, U., and Blutsch, H. 1976. DNA-dependent DNA polymerase from yeast 
mitochondria. Dependence of enzyme activity on conditions of cell growth, and properties of the 
highly purified polymerase. Eur. J. Biochem. 68, 199–207.  
54. Garcia-Gomez, S. et al. 2013. PrimPol, an archaic primase/polymerase operating in human 
cells. Mol Cell 52, 541–553. 
55.  Genga A, Bianch L, Foury F. 1986 A nuclear mutant of Saccharomyces cerevisiae deficient 
in mitochondrial DNA replication and polymerase activity. Journal of Biological Chemistry. 
261, 9328-9332. 
56. Nicole Hance, Mats I. Ekstrand, Aleksandra Trifunovic; 2005. Mitochondrial DNA 
polymerase gamma is essential for mammalian embryogenesis, Human Molecular Genetics  
14;13: 1775–1783 
57. Chan S, Copeland W. 2009. DNA polymerase gamma and mitochondrial disease: 
understanding the consequence of POLG mutations. Biochem Biophys Acta.  1787(5); 312-319. 
58. Young M. J., Theriault S. S., Li M., Court D. A. 2006. The carboxyl-terminal extension on 
fungal mitochondrial DNA polymerases: identification of a critical region of the enzyme from 
Saccharomyces cerevisiae. Yeast 23, 101–116.  
59. Hu J. P., Vanderstraeten S., Foury F. 1995. Isolation and characterization of ten mutator 
alleles of the mitochondrial DNA polymerase-encoding MIP1 gene from Saccharomyces 
cerevisiae. Gene 160, 105–110.  
60. Ropp P, Copeland W. Characterization of a new DNA polymerase from 
Schizosaccharomyces pombe: a probable homologue of the Saccharomyces cerevisiae DNA 
polymerase gamma. Gene. 7;165(1):103-7 
	 63 
61. Ropp P, Copeland W. 1996. Cloning and characterization of the human mitochondrial DNA 
polymerase, DNA polymerase gamma. Genomics. 15;36(3):449-458. 
62. Ye F, Carrodeguas JA, Bogenhagen DF. 1996. The gamma subfamily of DNA polymerases: 
cloning of a developmentally regulated cDNA encoding Xenopus laevis mitochondrial DNA 
polymerase gamma. Nucleic Acids Research. 24(8):1481-1488. 
63. Lewis D, Farr C, Want Y, Lagina A, Kaguni L. Catalytic Subunit of Mitochondrial DNA 
Polymerase from Drosophila Embryos Cloning, Bacterial Overexpression, and Biochemical 
Characterization. JBC. 271, 23389-23394. 
64. Foury F., Vanderstraeten S. 1992. Yeast mitochondrial DNA mutators with deficient 
proofreading exonucleolytic activity. EMBO J. 11, 2717–2726. 
65. Trifunovic A, Wredeberg A, Falkenberg M, et al. 2004. Premature ageing in mice expressing 
defective mitochondrial DNA polymerase. Nature. 429, 417-423. 
66.Lee Y. S., Kennedy W. D., Yin Y. W. 2009. Structural insight into processive human 
mitochondrial DNA synthesis and disease-related polymerase mutations. Cell 139, 312–324.  
67. Lim SE, Longley MJ, Copeland WC. 1999. The mitochondrial p55 accessory subunit of 
human DNA polymerase gamma enhances DNA binding, promotes processive DNA synthesis, 
and confers N-ethylmaleimide resistance. J Biol Chem. 274:38197–38203. 
68. 97. Wernette C. M. Kaguni L. S. 1986. A Mitochondrial DNA Polymerase from Embryos of 
Drosophila melanogaster. J. Biol. Chem. 261:14764-14770 
69. Viikov K., Väljamäe P., Sedman J. 2011. Yeast mitochondrial DNA polymerase is a highly 
processive single-subunit enzyme. Mitochondrion 11, 119–126.  
	 64 
70. Viikov K., Jasnovidova O., Tamm T., Sedman J. 2012. C-terminal extension of the yeast 
mitochondrial DNA polymerase determines the balance between synthesis and degradation. 
PLoS ONE 7:e33482.  
71. Graziewicz M, Longley M, Copeland W. 2006. DNA Polymerase Gamma in Mitochondrial 
DNA Replication and Repair. Chem rev. 106, 383-405. 
72. Maier D, Farr CL, Poeck B, et al. 2001. Mitochondrial Single-stranded DNA-binding Protein 
Is Required for Mitochondrial DNA Replication and Development in Drosophila melanogaster. 
Fox TD, ed. Molecular Biology of the Cell. 12(4):821-830. 
73. Maier D, Farr CL, Poeck B, et al. 2001. Mitochondrial Single-stranded DNA-binding Protein 
Is Required for Mitochondrial DNA Replication and Development in Drosophila melanogaster. 
Fox TD, ed. Molecular Biology of the Cell. 12(4):821-830. 
74. Tyynismaa H, Sembongi H, Brown M, et al. 2004. Twinkle helicase is essential for mtDNA 
maintenance and regulates mtDNA copy number. Human Molecular Genetics. 13;24 3219-3227. 
75. Cerritelli S, Frolova E, Feng C, Grinberg A, Love P, Crouch R. 2003. Failure to Produce 
Mitochondrial DNA Results in Embryonic Lethality in Rnaseh1 Null Mice. Molecular Cell. 11;3 
807-815. 
76. Bose I, Doering T. 2011. Efficient implementation of RNA interference in the pathogenic 
yeast Cryptococcus neoformans. J Microbiol Methods. 86(2):156-15. 
77. Zhang H, Barceló JM, Lee B, et al. 2001. Human mitochondrial topoisomerase I. 
Proceedings of the National Academy of Sciences of the United States of America. 98(19):10608-
10613.  
	 65 
78. Li M.Z., Elledge S.J. 2012. SLIC: A Method for Sequence- and Ligation-Independent 
Cloning. In: Peccoud J. (eds) Gene Synthesis. Methods in Molecular Biology (Methods and 
Protocols), vol 852. Humana Press 
79. Ory, J. J., Griffith, C. L. and Doering, T. L. 2004. An efficiently regulated promoter system 
for Cryptococcus neoformans utilizing the CTR4 promoter. Yeast, 21: 919–926.  
80. Dougherty, R. (2005), "Extensions of DAMAS and Benefits and Limitations of 
Deconvolution in Beamforming", 11th AIAA/CEAS Aeroacoustics Conference (26th AIAA 
Aeroacoustics Conference). 
81. Lodi T, Dallabona C, Nolli C, Goffrini P, Donnini C, Baruffini E. 2015. DNA polymerase 
gamma and disease: what we have learned from yeast. Front Genet. 6: 106. 
82. Kwon-Chung KJ, Varma A, Edman JC, Bennett JE. 1992. Selection of ura5 and ura3 mutants 
from the two varieties of Cryptococcus neoformans on 5-fluroorotic acid medium. J Med Vet 
Mycol. 30(1):61-9. 
83. Hong L, Cottrell T, Pierini L, Goldman W, Doering T. 2002. RNA Interference in the 
Pathogenic Fungus Cryptococcus neoformans. Genetics 160(2):463-470. 
84. Lin X, Heitman J. 2006. The Biology of the Cryptococcus neoformans Species Complex. 
Annu. Rev. Microbiol, 60:69-105. 
  
	 66 
APPENDIX 
 
	 67 
 
	 68 
 
Figure 19. (S1). Protein alignment of S. cerevisiae polG and C. neoformans polG homolog. 
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Figure 20. (S2). Protein alignment of JEC21 (Serotype D) (top) and H99 (Serotype A) (bottom) 
C. neoformans DNA polymerase gamma. 
 
